Cargando…

Performance and Robustness Testing of a Non-Invasive Mapping System for Ventricular Arrhythmias

Background: The clinical value of non-invasive mapping system depends on its accuracy under common variations of the inputs. The View Into Ventricular Onset (VIVO) system matches simulated QRS complexes of a patient-specific anatomical model with a 12-lead ECG to estimate the origin of ventricular a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lesina, Krista, Szili-Torok, Tamas, Peters, Emile, de Wit, André, Wijchers, Sip A., Bhagwandien, Rohit E., Yap, Sing-Chien, Hirsch, Alexander, Hoogendijk, Mark G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086357/
https://www.ncbi.nlm.nih.gov/pubmed/35557970
http://dx.doi.org/10.3389/fphys.2022.870435
_version_ 1784703980900712448
author Lesina, Krista
Szili-Torok, Tamas
Peters, Emile
de Wit, André
Wijchers, Sip A.
Bhagwandien, Rohit E.
Yap, Sing-Chien
Hirsch, Alexander
Hoogendijk, Mark G.
author_facet Lesina, Krista
Szili-Torok, Tamas
Peters, Emile
de Wit, André
Wijchers, Sip A.
Bhagwandien, Rohit E.
Yap, Sing-Chien
Hirsch, Alexander
Hoogendijk, Mark G.
author_sort Lesina, Krista
collection PubMed
description Background: The clinical value of non-invasive mapping system depends on its accuracy under common variations of the inputs. The View Into Ventricular Onset (VIVO) system matches simulated QRS complexes of a patient-specific anatomical model with a 12-lead ECG to estimate the origin of ventricular arrhythmias. We aim to test the performance of the VIVO system and its sensitivity to changes in the anatomical model, time marker placement to demarcate the QRS complex and body position. Methods: Non-invasive activation maps of idiopathic premature ventricular complexes (PVCs) using a patient-specific or generic anatomical model were matched with the location during electrophysiological studies. Activation maps were analyzed before and after systematically changing the time marker placement. Morphologically identical PVCs recorded in supine and sitting position were compared in a subgroup. Results: Non-invasive activation maps of 48 patients (age 51 ± 14 years, 28 female) were analyzed. The origin of the PVCs as determined by VIVO system matched with the clinical localization in 36/48 (75%) patients. Mismatches were more common for PVCs of left than right ventricular origin [11/27 (41%) vs. 1/21 (5%) of cases, p < 0.01]. The first 32 cases were analyzed for robustness testing of the VIVO system. Changing the patient-specific vs. the generic anatomical model reduced the accuracy from 23/32 (72%) to 15/32 (47%), p < 0.05. Time marker placement in the QRS complex (delayed onset or advanced end marker) or in the ST-segment (delaying the QRS complex end marker) resulted in progressive shifts in origins of PVCs. Altered body positions did not change the predicted origin of PVCs in most patients [clinically unchanged 11/15 (73%)]. Conclusion: VIVO activation mapping is sensitive to changes in the anatomical model and time marker placement but less to altered body position.
format Online
Article
Text
id pubmed-9086357
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90863572022-05-11 Performance and Robustness Testing of a Non-Invasive Mapping System for Ventricular Arrhythmias Lesina, Krista Szili-Torok, Tamas Peters, Emile de Wit, André Wijchers, Sip A. Bhagwandien, Rohit E. Yap, Sing-Chien Hirsch, Alexander Hoogendijk, Mark G. Front Physiol Physiology Background: The clinical value of non-invasive mapping system depends on its accuracy under common variations of the inputs. The View Into Ventricular Onset (VIVO) system matches simulated QRS complexes of a patient-specific anatomical model with a 12-lead ECG to estimate the origin of ventricular arrhythmias. We aim to test the performance of the VIVO system and its sensitivity to changes in the anatomical model, time marker placement to demarcate the QRS complex and body position. Methods: Non-invasive activation maps of idiopathic premature ventricular complexes (PVCs) using a patient-specific or generic anatomical model were matched with the location during electrophysiological studies. Activation maps were analyzed before and after systematically changing the time marker placement. Morphologically identical PVCs recorded in supine and sitting position were compared in a subgroup. Results: Non-invasive activation maps of 48 patients (age 51 ± 14 years, 28 female) were analyzed. The origin of the PVCs as determined by VIVO system matched with the clinical localization in 36/48 (75%) patients. Mismatches were more common for PVCs of left than right ventricular origin [11/27 (41%) vs. 1/21 (5%) of cases, p < 0.01]. The first 32 cases were analyzed for robustness testing of the VIVO system. Changing the patient-specific vs. the generic anatomical model reduced the accuracy from 23/32 (72%) to 15/32 (47%), p < 0.05. Time marker placement in the QRS complex (delayed onset or advanced end marker) or in the ST-segment (delaying the QRS complex end marker) resulted in progressive shifts in origins of PVCs. Altered body positions did not change the predicted origin of PVCs in most patients [clinically unchanged 11/15 (73%)]. Conclusion: VIVO activation mapping is sensitive to changes in the anatomical model and time marker placement but less to altered body position. Frontiers Media S.A. 2022-04-26 /pmc/articles/PMC9086357/ /pubmed/35557970 http://dx.doi.org/10.3389/fphys.2022.870435 Text en Copyright © 2022 Lesina, Szili-Torok, Peters, de Wit, Wijchers, Bhagwandien, Yap, Hirsch and Hoogendijk. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Lesina, Krista
Szili-Torok, Tamas
Peters, Emile
de Wit, André
Wijchers, Sip A.
Bhagwandien, Rohit E.
Yap, Sing-Chien
Hirsch, Alexander
Hoogendijk, Mark G.
Performance and Robustness Testing of a Non-Invasive Mapping System for Ventricular Arrhythmias
title Performance and Robustness Testing of a Non-Invasive Mapping System for Ventricular Arrhythmias
title_full Performance and Robustness Testing of a Non-Invasive Mapping System for Ventricular Arrhythmias
title_fullStr Performance and Robustness Testing of a Non-Invasive Mapping System for Ventricular Arrhythmias
title_full_unstemmed Performance and Robustness Testing of a Non-Invasive Mapping System for Ventricular Arrhythmias
title_short Performance and Robustness Testing of a Non-Invasive Mapping System for Ventricular Arrhythmias
title_sort performance and robustness testing of a non-invasive mapping system for ventricular arrhythmias
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086357/
https://www.ncbi.nlm.nih.gov/pubmed/35557970
http://dx.doi.org/10.3389/fphys.2022.870435
work_keys_str_mv AT lesinakrista performanceandrobustnesstestingofanoninvasivemappingsystemforventriculararrhythmias
AT szilitoroktamas performanceandrobustnesstestingofanoninvasivemappingsystemforventriculararrhythmias
AT petersemile performanceandrobustnesstestingofanoninvasivemappingsystemforventriculararrhythmias
AT dewitandre performanceandrobustnesstestingofanoninvasivemappingsystemforventriculararrhythmias
AT wijcherssipa performanceandrobustnesstestingofanoninvasivemappingsystemforventriculararrhythmias
AT bhagwandienrohite performanceandrobustnesstestingofanoninvasivemappingsystemforventriculararrhythmias
AT yapsingchien performanceandrobustnesstestingofanoninvasivemappingsystemforventriculararrhythmias
AT hirschalexander performanceandrobustnesstestingofanoninvasivemappingsystemforventriculararrhythmias
AT hoogendijkmarkg performanceandrobustnesstestingofanoninvasivemappingsystemforventriculararrhythmias